Minimal Residual Disease Market: Key Drivers, Challenges, and Emerging Opportunities
The Minimal Residual Disease Market is experiencing remarkable growth as healthcare providers increasingly adopt highly sensitive diagnostic technologies to detect residual cancer cells following treatment. Minimal residual disease (MRD) assessment has become an essential component of modern oncology, enabling physicians to identify microscopic levels of disease that remain undetectable through...
0 Commentarii 0 Distribuiri 22 Views 0 previzualizare